Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Translational Advances of Hydrofection by Hydrodynamic Injection.

Sendra L, Herrero MJ, Aliño SF.

Genes (Basel). 2018 Mar 1;9(3). pii: E136. doi: 10.3390/genes9030136. Review.

2.

Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia.

Megias-Vericat JE, Martinez-Cuadron D, Herrero MJ, Alino SF, Poveda JL, Sanz MA, Montesinos P.

Curr Drug Metab. 2018;19(1):55-74. doi: 10.2174/1389200218666171101124931.

PMID:
29090664
3.

Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment.

Megías-Vericat JE, Montesinos P, Herrero MJ, Moscardó F, Bosó V, Martínez-Cuadrón D, Rojas L, Rodríguez-Veiga R, Boluda B, Sendra L, Cervera J, Poveda JL, Sanz MÁ, Aliño SF.

Leuk Lymphoma. 2017 Dec;58(12):2880-2894. doi: 10.1080/10428194.2017.1323267. Epub 2017 Jun 2.

PMID:
28573946
4.

Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia.

Megías-Vericat JE, Montesinos P, Herrero MJ, Moscardó F, Bosó V, Martínez-Cuadrón D, Poveda JL, Sanz MÁ, Aliño SF.

Pharmacogenet Genomics. 2017 Jul;27(7):270-274. doi: 10.1097/FPC.0000000000000286.

PMID:
28570300
5.

Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy.

Megías-Vericat JE, Montesinos P, Herrero MJ, Moscardó F, Bosó V, Rojas L, Martínez-Cuadrón D, Rodríguez-Veiga R, Sendra L, Cervera J, Poveda JL, Sanz MÁ, Aliño SF.

Pharmacogenomics J. 2018 Apr;18(2):301-307. doi: 10.1038/tpj.2017.19. Epub 2017 May 9.

PMID:
28485375
6.

Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma.

Miguel A, Sendra L, Noé V, Ciudad CJ, Dasí F, Hervas D, Herrero MJ, Aliño SF.

Onco Targets Ther. 2017 Jan 23;10:503-514. doi: 10.2147/OTT.S104393. eCollection 2017.

7.

Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.

Megías-Vericat JE, Montesinos P, Herrero MJ, Moscardó F, Bosó V, Rojas L, Martínez-Cuadrón D, Hervás D, Boluda B, García-Robles A, Rodríguez-Veiga R, Martín-Cerezuela M, Cervera J, Sendra L, Sanz J, Miguel A, Lorenzo I, Poveda JL, Sanz MÁ, Aliño SF.

Leuk Lymphoma. 2017 May;58(5):1197-1206. doi: 10.1080/10428194.2016.1231405. Epub 2016 Oct 4.

PMID:
27701910
8.

Studying Closed Hydrodynamic Models of "In Vivo" DNA Perfusion in Pig Liver for Gene Therapy Translation to Humans.

Sendra L, Miguel A, Pérez-Enguix D, Herrero MJ, Montalvá E, García-Gimeno MA, Noguera I, Díaz A, Pérez J, Sanz P, López-Andújar R, Martí-Bonmatí L, Aliño SF.

PLoS One. 2016 Oct 3;11(10):e0163898. doi: 10.1371/journal.pone.0163898. eCollection 2016.

9.

Pharmacogenomics and the treatment of acute myeloid leukemia.

Megías-Vericat JE, Montesinos P, Herrero MJ, Bosó V, Martínez-Cuadrón D, Poveda JL, Sanz MÁ, Aliño SF.

Pharmacogenomics. 2016 Jul;17(11):1245-1272. Epub 2016 Jul 6. Review.

PMID:
27381050
10.

A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia.

Megías-Vericat JE, Herrero MJ, Rojas L, Montesinos P, Bosó V, Moscardó F, Martínez-Cuadrón D, Poveda JL, Sanz MÁ, Aliño SF.

Pharmacogenomics J. 2016 Feb;16(1):30-40. doi: 10.1038/tpj.2015.80. Epub 2015 Dec 8. Review.

PMID:
26644203
11.

Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis.

Megías-Vericat JE, Rojas L, Herrero MJ, Bosó V, Montesinos P, Moscardó F, Poveda JL, Sanz MA, Aliño SF.

Pharmacogenomics J. 2016 Feb;16(1):1-2. doi: 10.1038/tpj.2015.79. Epub 2015 Oct 27. Review. No abstract available.

PMID:
26503809
12.

Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation.

Ruiz J, Herrero MJ, Bosó V, Megías JE, Hervás D, Poveda JL, Escrivá J, Pastor A, Solé A, Aliño SF.

Int J Mol Sci. 2015 Aug 25;16(9):20168-82. doi: 10.3390/ijms160920168.

13.

Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation.

Sánchez-Lázaro I, Herrero MJ, Jordán-De Luna C, Bosó V, Almenar L, Rojas L, Martínez-Dolz L, Megías-Vericat JE, Sendra L, Miguel A, Poveda JL, Aliño SF.

Pharmacogenomics. 2015;16(9):971-9. doi: 10.2217/pgs.15.39. Epub 2015 Jun 24.

PMID:
26107754
14.

Human AAT gene transfer to pig liver improved by using a perfusion isolated organ endovascular procedure.

Sendra L, Pérez D, Miguel A, Herrero MJ, Noguera I, Díaz A, Barettino D, Martí-Bonmatí L, Aliño SF.

Eur Radiol. 2016 Jan;26(1):95-102. doi: 10.1007/s00330-015-3792-2. Epub 2015 Apr 25.

PMID:
25911616
15.

Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: a systematic review and meta-analysis of observational studies.

Megías-Vericat JE, Rojas L, Herrero MJ, Bosó V, Montesinos P, Moscardó F, Poveda JL, Sanz MÁ, Aliño SF.

Pharmacogenomics J. 2015 Apr;15(2):109-18. doi: 10.1038/tpj.2014.80. Epub 2015 Jan 6.

PMID:
25558979
16.

SNPs and taxane toxicity in breast cancer patients.

Bosó V, Herrero MJ, Santaballa A, Palomar L, Megias JE, de la Cueva H, Rojas L, Marqués MR, Poveda JL, Montalar J, Aliño SF.

Pharmacogenomics. 2014;15(15):1845-58. doi: 10.2217/pgs.14.127.

PMID:
25495407
17.

Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies.

Rojas L, Neumann I, Herrero MJ, Bosó V, Reig J, Poveda JL, Megías J, Bea S, Aliño SF.

Pharmacogenomics J. 2015 Feb;15(1):38-48. doi: 10.1038/tpj.2014.38. Epub 2014 Sep 9. Review.

PMID:
25201288
18.

Low RNA translation activit limits the efficacy of hydrodynamic gene transfer to pig liver in vivo.

Sendra L, Carreño O, Miguel A, Montalvá E, Herrero MJ, Orbis F, Noguera I, Barettino D, López-Andújar R, Aliño SF.

J Gene Med. 2014 Jul-Aug;16(7-8):179-92. doi: 10.1002/jgm.2777.

PMID:
25092576
19.

Antitumor cell-complex vaccines employing genetically modified tumor cells and fibroblasts.

Miguel A, Herrero MJ, Sendra L, Botella R, Diaz A, Algás R, Aliño SF.

Toxins (Basel). 2014 Feb 19;6(2):636-49. doi: 10.3390/toxins6020636.

20.

Genotype and allele frequencies of drug-metabolizing enzymes and drug transporter genes affecting immunosuppressants in the Spanish white population.

Bosó V, Herrero MJ, Buso E, Galán J, Almenar L, Sánchez-Lázaro I, Sánchez-Plumed J, Bea S, Prieto M, García M, Pastor A, Sole A, Poveda JL, Aliño SF.

Ther Drug Monit. 2014 Apr;36(2):159-68. doi: 10.1097/FTD.0b013e3182a94e65.

PMID:
24232128
21.

A surgical model for isolating the pig liver in vivo for gene therapy.

Carreño O, Sendra L, Montalvá E, Miguel A, Orbis F, Herrero MJ, Noguera I, Aliño SF, Lopez-Andujar R.

Eur Surg Res. 2013;51(1-2):47-57. doi: 10.1159/000351339. Epub 2013 Sep 10.

PMID:
24022646
22.

Comparative antitumor effect among GM-CSF, IL-12 and GM-CSF+IL-12 genetically modified tumor cell vaccines.

Miguel A, Herrero MJ, Sendra L, Botella R, Algás R, Sánchez M, Aliño SF.

Cancer Gene Ther. 2013 Oct;20(10):576-81. doi: 10.1038/cgt.2013.54. Epub 2013 Aug 23.

PMID:
23969885
23.

Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation.

Rojas LE, Herrero MJ, Bosó V, García-Eliz M, Poveda JL, Librero J, Aliño SF.

Pharmacogenet Genomics. 2013 Oct;23(10):509-17. doi: 10.1097/FPC.0b013e3283642fb3. Review.

PMID:
23873120
24.

Comparative antitumor effect of preventive versus therapeutic vaccines employing B16 melanoma cells genetically modified to express GM-CSF and B7.2 in a murine model.

Miguel A, Herrero MJ, Sendra L, Botella R, Algás R, Sánchez M, Aliño SF.

Toxins (Basel). 2012 Oct 31;4(11):1058-81. doi: 10.3390/toxins4111058.

25.

Increased hospital stay and allograft dysfunction in renal transplant recipients with Cyp2c19 AA variant in SNP rs4244285.

Bosó V, Herrero MJ, Bea S, Galiana M, Marrero P, Marqués MR, Hernández J, Sánchez-Plumed J, Poveda JL, Aliño SF.

Drug Metab Dispos. 2013 Feb;41(2):480-7. doi: 10.1124/dmd.112.047977. Epub 2012 Nov 21.

26.

Cell-free circulating plasma hTERT mRNA is a useful marker for prostate cancer diagnosis and is associated with poor prognosis tumor characteristics.

March-Villalba JA, Martínez-Jabaloyas JM, Herrero MJ, Santamaria J, Aliño SF, Dasí F.

PLoS One. 2012;7(8):e43470. doi: 10.1371/journal.pone.0043470. Epub 2012 Aug 20.

27.

Plasma hTERT mRNA discriminates between clinically localized and locally advanced disease and is a predictor of recurrence in prostate cancer patients.

March-Villalba JA, Martínez-Jabaloyas JM, Herrero MJ, Santamaría J, Aliño SF, Dasí F.

Expert Opin Biol Ther. 2012 Jun;12 Suppl 1:S69-77. doi: 10.1517/14712598.2012.685716. Epub 2012 May 5.

PMID:
22559196
28.

DNA delivery to 'ex vivo' human liver segments.

Herrero MJ, Sabater L, Guenechea G, Sendra L, Montilla AI, Abargues R, Navarro V, Aliño SF.

Gene Ther. 2012 May;19(5):504-12. doi: 10.1038/gt.2011.144. Epub 2011 Oct 13.

PMID:
21993175
29.

Analysis of metabolic and gene expression changes after hydrodynamic DNA injection into mouse liver.

Herrero MJ, Monleon D, Morales JM, Mata M, Serna E, Aliño SF.

Biol Pharm Bull. 2011;34(1):167-72.

30.

Clinical interest of pharmacogenetic polymorphisms in the immunosuppressive treatment after heart transplantation.

Herrero MJ, Almenar L, Jordán C, Sánchez I, Poveda JL, Aliño SF.

Transplant Proc. 2010 Oct;42(8):3181-2. doi: 10.1016/j.transproceed.2010.05.129.

PMID:
20970643
31.

Influence of pharmacogenetic polymorphisms in routine immunosuppression therapy after renal transplantation.

Herrero MJ, Sánchez-Plumed J, Galiana M, Bea S, Marqués MR, Aliño SF.

Transplant Proc. 2010 Oct;42(8):3134-6. doi: 10.1016/j.transproceed.2010.05.122.

PMID:
20970628
32.

Naked DNA delivery to whole pig cardiac tissue by coronary sinus retrograde injection employing non-invasive catheterization.

Aliño SF, José Herrero M, Bodi V, Noguera I, Mainar L, Dasí F, Sempere A, Sánchez M, Díaz A, Sabater L, Lledó S.

J Gene Med. 2010 Nov;12(11):920-6. doi: 10.1002/jgm.1510. Epub 2010 Oct 22.

PMID:
20967894
33.

The DD genotype of the angiotensin converting enzyme gene independently associates with CMR-derived abnormal microvascular perfusion in patients with a first anterior ST-segment elevation myocardial infarction treated with thrombolytic agents.

Bodi V, Sanchis J, Nunez J, Aliño SF, Herrero MJ, Chorro FJ, Mainar L, Lopez-Lereu MP, Monmeneu JV, Oltra R, Chaustre F, Forteza MJ, Husser O, Riegger GA, Llacer A.

Thromb Res. 2009 Dec;124(6):e56-61. doi: 10.1016/j.thromres.2009.07.009. Epub 2009 Aug 7.

PMID:
19664801
34.

Bead-selected antitumor genetic cell vaccines.

Herrero M, R B, R A, Marco F, Aliño S.

Clin Med Oncol. 2008;2:257-65. Epub 2008 Mar 25.

35.

Antigens and cytokine genes in antitumor vaccines: the importance of the temporal delivery sequence in antitumor signals.

Herrero MJ, Botella R, Dasí F, Algás R, Sánchez M, Aliño SF.

Ann N Y Acad Sci. 2006 Dec;1091:412-24.

PMID:
17341632
36.

Real-time quantification of human telomerase reverse transcriptase mRNA in the plasma of patients with prostate cancer.

Dasí F, Martínez-Rodes P, March JA, Santamaría J, Martínez-Javaloyas JM, Gil M, Aliño SF.

Ann N Y Acad Sci. 2006 Sep;1075:204-10.

PMID:
17108213
37.

Pig liver gene therapy by noninvasive interventionist catheterism.

Aliño SF, Herrero MJ, Noguera I, Dasí F, Sánchez M.

Gene Ther. 2007 Feb;14(4):334-43. Epub 2006 Oct 12.

PMID:
17036058
38.

Nonviral therapeutic cell vaccine mediates potent antitumor effects.

Moret-Tatay I, Sanmartín I, Marco FM, Díaz J, Aliño SF.

Vaccine. 2006 May 1;24(18):3937-45. Epub 2006 Feb 21.

PMID:
16530895
39.

Antisense gene therapy using anti-k-ras and antitelomerase oligonucleotides in colorectal cancer.

Lledó S, Alfonso R, Aliño SF.

Rev Esp Enferm Dig. 2005 Jul;97(7):472-80. English, Spanish.

40.

Hydrodynamic liver gene transfer mechanism involves transient sinusoidal blood stasis and massive hepatocyte endocytic vesicles.

Crespo A, Peydró A, Dasí F, Benet M, Calvete JJ, Revert F, Aliño SF.

Gene Ther. 2005 Jun;12(11):927-35.

PMID:
15729372
41.

Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer.

Lledó SM, Garcia-Granero E, Dasí F, Ripoli R, García SA, Cervantes A, Aliño SF.

Colorectal Dis. 2004 Jul;6(4):236-42.

PMID:
15206965
42.

Asialofetuin liposomes for receptor-mediated gene transfer into hepatic cells.

Aliño SF, Benet M, Dasí F, Crespo J.

Methods Enzymol. 2003;373:399-421. No abstract available.

PMID:
14714418
43.

Complete tumor prevention by engineered tumor cell vaccines employing nonviral vectors.

Moret-Tatay I, Díaz J, Marco FM, Crespo A, Aliño SF.

Cancer Gene Ther. 2003 Dec;10(12):887-97.

PMID:
14712315
44.
45.

Targeted oligonucleotide delivery in human lymphoma cell lines using a polyethyleneimine based immunopolyplex.

Guillem VM, Tormo M, Moret I, Benet I, García-Conde J, Crespo A, Aliño SF.

J Control Release. 2002 Sep 18;83(1):133-46.

PMID:
12220845
46.

Polyethyleneimine-based immunopolyplex for targeted gene transfer in human lymphoma cell lines.

Guillem VM, Tormo M, Revert F, Benet I, García-Conde J, Crespo A, Aliño SF.

J Gene Med. 2002 Mar-Apr;4(2):170-82.

PMID:
11933218
47.

Stability of PEI-DNA and DOTAP-DNA complexes: effect of alkaline pH, heparin and serum.

Moret I, Esteban Peris J, Guillem VM, Benet M, Revert F, Dasí F, Crespo A, Aliño SF.

J Control Release. 2001 Sep 11;76(1-2):169-81.

PMID:
11532322
48.

Asialofetuin liposome-mediated human alpha1-antitrypsin gene transfer in vivo results in stationary long-term gene expression.

Dasí F, Benet M, Crespo J, Crespo A, Aliño SF.

J Mol Med (Berl). 2001 May;79(4):205-12.

PMID:
11409712
49.

Antitumor effect of B16 melanoma cells genetically modified with the angiogenesis inhibitor rnasin.

Botella-Estrada R, Malet G, Revert F, Dasí F, Crespo A, Sanmartín O, Guillén C, Aliño SF.

Cancer Gene Ther. 2001 Apr;8(4):278-84.

50.

Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: a simple blood test to monitor disease in cancer patients.

Dasí F, Lledó S, García-Granero E, Ripoll R, Marugán M, Tormo M, García-Conde J, Aliño SF.

Lab Invest. 2001 May;81(5):767-9. No abstract available.

PMID:
11351048

Supplemental Content

Loading ...
Support Center